Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Transgenic medaka that overexpress growth hormone have a skin color that does not indicate the activation or inhibition of somatolactin-α signal.

Komine R, Nishimaki T, Kimura T, Oota H, Naruse K, Homma N, Fukamachi S.

Gene. 2016 Jun 10;584(1):38-46. doi: 10.1016/j.gene.2016.02.046. Epub 2016 Mar 3.

PMID:
26945627
2.

Visualization of Grain Structure and Boundaries of Polycrystalline Graphene and Two-Dimensional Materials by Epitaxial Growth of Transition Metal Dichalcogenides.

Ago H, Fukamachi S, Endo H, Solís-Fernández P, Mohamad Yunus R, Uchida Y, Panchal V, Kazakova O, Tsuji M.

ACS Nano. 2016 Mar 22;10(3):3233-40. doi: 10.1021/acsnano.5b05879. Epub 2016 Mar 10.

PMID:
26943750
3.

Effects of body-color mutations on vitality: an attempt to establish easy-to-breed see-through medaka strains by outcrossing.

Ohshima A, Morimura N, Matsumoto C, Hiraga A, Komine R, Kimura T, Naruse K, Fukamachi S.

G3 (Bethesda). 2013 Sep 4;3(9):1577-85. doi: 10.1534/g3.113.007575.

4.

D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells.

Mori T, Kabashima K, Fukamachi S, Kuroda E, Sakabe J, Kobayashi M, Nakajima S, Nakano K, Tanaka Y, Matsushita S, Nakamura M, Tokura Y.

J Dermatol Sci. 2013 Jul;71(1):37-44. doi: 10.1016/j.jdermsci.2013.03.008. Epub 2013 Apr 10.

PMID:
23639699
5.

Establishment of HRAS(G12V) transgenic medaka as a stable tumor model for in vivo screening of anticancer drugs.

Matsuzaki Y, Hosokai H, Mizuguchi Y, Fukamachi S, Shimizu A, Saya H.

PLoS One. 2013;8(1):e54424. doi: 10.1371/journal.pone.0054424. Epub 2013 Jan 14.

6.

Bilateral stenosis of carotid siphon in Hutchinson-Gilford progeria syndrome.

Narazaki R, Makimura M, Sanefuji M, Fukamachi S, Akiyoshi H, So H, Yamamura K, Doisaki S, Kojima S, Ihara K, Hara T, Ohga S.

Brain Dev. 2013 Aug;35(7):690-3. doi: 10.1016/j.braindev.2012.10.008. Epub 2012 Nov 8.

PMID:
23141186
7.

[A case of huge advanced rectal cancer resected successfully after chemotherapy with mFOLFOX6].

Kobayashi T, Tsukidate H, Fukamachi S, Ikezawa F, Endo K, Suzuki Y, Nakagawa K, Tezuka F.

Gan To Kagaku Ryoho. 2012 Aug;39(8):1271-3. Japanese.

PMID:
22902457
8.

Reassessment of the function of somatolactin alpha in lipid metabolism using medaka mutant and transgenic strains.

Sasano Y, Yoshimura A, Fukamachi S.

BMC Genet. 2012 Jul 24;13:64. doi: 10.1186/1471-2156-13-64.

9.

Validity of the six stages of change for exercise.

Horiuchi S, Tsuda A, Watanabe Y, Fukamachi S, Samejima S.

J Health Psychol. 2013 Apr;18(4):518-27. doi: 10.1177/1359105312437262. Epub 2012 Jun 18.

PMID:
22710152
10.

Three cases of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas.

Shirakawa H, Kikuchi E, Mikami S, Fukamachi S, Miyazaki Y, Tanaka N, Miyajima A, Oya M.

Scand J Urol Nephrol. 2012 Apr;46(2):136-41. doi: 10.3109/00365599.2011.644863. Epub 2012 Jan 18.

PMID:
22251056
11.

Tuberculosis verrucosa cutis with elevation of circulating T-helper 1 and 17 cells and their reductions after successful treatment.

Fukamachi S, Kawakami C, Kabashima R, Sawada Y, Sugita K, Nakamura M, Yatera K, Tokura Y.

J Dermatol. 2012 May;39(5):507-9. doi: 10.1111/j.1346-8138.2011.01317.x. Epub 2011 Dec 2. No abstract available.

PMID:
22133262
12.

Cutaneous pseudolymphoma due to benidipine hydrochloride with massive infiltration of eosinophils.

Fukamachi S, Sugita K, Nakamura M, Tokura Y.

J Dermatol. 2011 Sep;38(9):935-7. No abstract available.

PMID:
21998837
13.

Synchronous bilateral neuroendocrine ductal carcinoma in situ.

Honami H, Sotome K, Sakamoto G, Iri H, Tanaka Y, Fukamachi S, Morozumi K.

Breast Cancer. 2014 Jul;21(4):508-13. doi: 10.1007/s12282-011-0278-1. Epub 2011 Jul 7.

PMID:
21735237
14.

Molecular mapping of lymph node metastases by real-time reverse transcription polymerase chain reaction in two melanoma patients.

Abe-Mukumoto S, Mori T, Hino R, Sakabe J, Fukamachi S, Bito T, Nakamura M, Kabashima K, Tokura Y.

J Dermatol. 2011 Dec;38(12):1202-5. doi: 10.1111/j.1346-8138.2011.01204.x. Epub 2011 Mar 21. No abstract available.

PMID:
21434988
15.

Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma.

Sawada Y, Hino R, Hama K, Ohmori S, Fueki H, Yamada S, Fukamachi S, Tajiri M, Kubo R, Yoshioka M, Nakashima D, Sugita K, Yoshiki R, Shimauchi T, Mori T, Izu K, Kobayashi M, Nakamura M, Tokura Y.

Blood. 2011 Apr 14;117(15):3961-7. doi: 10.1182/blood-2010-11-316794. Epub 2011 Feb 16.

16.

Topical cholecystokinin depresses itch-associated scratching behavior in mice.

Fukamachi S, Mori T, Sakabe J, Shiraishi N, Kuroda E, Kobayashi M, Bito T, Kabashima K, Nakamura M, Tokura Y.

J Invest Dermatol. 2011 Apr;131(4):956-61. doi: 10.1038/jid.2010.413. Epub 2011 Feb 3.

17.

Modulation of semaphorin 3A expression by calcium concentration and histamine in human keratinocytes and fibroblasts.

Fukamachi S, Bito T, Shiraishi N, Kobayashi M, Kabashima K, Nakamura M, Tokura Y.

J Dermatol Sci. 2011 Feb;61(2):118-23. doi: 10.1016/j.jdermsci.2010.11.012. Epub 2010 Dec 2.

PMID:
21176873
18.

Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption.

Sawada Y, Yoshiki R, Kawakami C, Fukamachi S, Sugita K, Nakamura M, Tokura Y.

Acta Derm Venereol. 2010 Sep;90(5):521-2. doi: 10.2340/00015555-0695. No abstract available.

19.

Cholinergic urticaria: studies on the muscarinic cholinergic receptor M3 in anhidrotic and hypohidrotic skin.

Sawada Y, Nakamura M, Bito T, Fukamachi S, Kabashima R, Sugita K, Hino R, Tokura Y.

J Invest Dermatol. 2010 Nov;130(11):2683-6. doi: 10.1038/jid.2010.188. Epub 2010 Jul 8. No abstract available.

20.

Genetic, comparative genomic, and expression analyses of the Mc1r locus in the polychromatic Midas cichlid fish (Teleostei, Cichlidae Amphilophus sp.) species group.

Henning F, Renz AJ, Fukamachi S, Meyer A.

J Mol Evol. 2010 May;70(5):405-12. doi: 10.1007/s00239-010-9340-4. Epub 2010 May 7.

PMID:
20449580
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk